Aledade, an independent primary care network, announced Tuesday that it has acquired value-based care analytics company Curia.
Bethesda, Maryland-based Aledade is a public benefit corporation with a focus on value-based care and aims to reduce…
Speculation as to whether or not the U.S. will soon be facing a recession has been a recurring conversation among economists as of late. Although popular belief leads many to assume that the healthcare…
Continue Reading
Editor’s note: This story is based on an interview at Abarca Forward, a conference that was hosted by Abarca Health, a pharmacy benefit manager last week in San Juan, Puerto Rico. MedCity News’ Editor-in-Chief…
Continue Reading
In this episode, Dr Bi Mian discusses his work with the Australian Medical Angels, a medical syndicate that focuses on investing in HealthTech startups in Australia. Mian, who is a medical doctor and runs…
Continue Reading
The home is re-emerging as the preferred place for patient care. Accelerated by the pandemic, a growing number of patients view the home as a more comfortable, safe, and convenient environment in which to…
Continue Reading
Travere Therapeutics has won FDA approval for a drug that treats a rare autoimmune disorder that is typically first noticed as blood in the urine and can progress over time to end-stage kidney failure.
The…
McKinsey estimates that digital health solutions could cut global healthcare costs by $3 trillion per year by 2030. But we’ll only hit that number if people actually use the digital health solutions we build…
Continue Reading
Blue Shield of California (BSC) created its Wellvolution platform, a collection of wellbeing apps, with the intention of helping members with their diet, exercise, sleep and overall health. But until last month, it has…
Continue Reading
About 40% of Physicians Health Plan of Northern Indiana (PHP) members don’t have a primary care physician. The health plan aims to change that through a new partnership.
PHP announced last week that it is…
Clotting disorders can be treated by infusing patients with clotting proteins they lack, or with drugs that replace the function of these proteins. Gene therapies may soon become another option. Hemophilia A and B…
Continue Reading
